TheraRadar
← Back
Data updated: Mar 29, 2026

SOLARIS PHARMA CORP

DermatologyCardiovascularOncology
Generics

SOLARIS PHARMA CORP is a generic drug manufacturer focused on Dermatology, Cardiovascular, Oncology.

2021
Since
6
Drugs
-
Trials
119
Approved (2yr)

Key Drugs

CLINDAMYCIN PHOSPHATE AND TRETINOIN
clindamycin phosphate
1 indications · 2015

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
ESTRADIOL 2026-02-02
ESTRADIOL 2026-01-22
Labeling
NITROGLYCERIN 2025-12-18
ESTRADIOL 2025-12-08
TAZAROTENE 2025-11-24
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 50%
2 drugs
Cardiovascular 25%
1 drugs
Oncology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Cardiovascular, Oncology, Dermatology
Bayer big-pharma
Oncology, Cardiovascular, Dermatology
COSETTE other
Cardiovascular, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Oncology, Cardiovascular
Pfizer big-pharma
Oncology, Dermatology